Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network (Q33514751)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network |
scientific article |
Statements
1 reference
Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network (English)
1 reference
Oscar Bertetto
1 reference
Alfredo Berruti
1 reference
Luigi Dogliotti
1 reference
Mauro Papotti
1 reference
Marco Volante
1 reference
Anna Ferrero
1 reference
Maria P Brizzi
1 reference
Enrica Milanesi
1 reference
Federico Castiglione
1 reference
Nadia Birocco
1 reference
Sebastiano Bombaci
1 reference
Davide Perroni
1 reference
Benedetta Ferretti
1 reference
Oscar Alabiso
1 reference
Libero Ciuffreda
1 reference
3 November 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference